Raymed Labs Ltd. - Research Center
531207 RAYLA Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
- |
- |
- |
- |
- |
Operating profit |
-0.03 |
-0.03 |
-0.07 |
-0.06 |
-0.02 |
Interest |
- |
- |
- |
- |
- |
Gross profit |
-0.03 |
-0.03 |
-0.07 |
-0.06 |
-0.02 |
EPS (Rs) |
-0.08 |
-0.08 |
-0.18 |
-0.14 |
-0.05 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
- |
- |
- |
- |
- |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.01 |
0.01 |
0.05 |
0.04 |
0.01 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
- |
- |
- |
- |
- |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-0.03 |
-0.03 |
-0.08 |
-0.06 |
-0.02 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.27 |
4.27 |
4.27 |
4.27 |
4.27 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
- |
- |
- |
- |
- |
GPM (%) |
- |
- |
- |
- |
- |
NPM (%) |
- |
- |
- |
- |
- |